NewsRoom Articles - Page 781 of 1390

ThursdayMay 23, 2019 4:00 pm

Corbus Pharmaceuticals Holdings Inc. (CRBP) Starts Presentation at B. Riley Conference

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is a phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The company's lead product candidate, lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor Type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. For more information,…

ThursdayMay 23, 2019 3:30 pm

Novavax Inc. (NVAX) Starts Presentation at B. Riley Conference

Novavax (NASDAQ: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, Novavax produces vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. The company’s vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis. Novavax’s product pipeline targets a variety of infectious diseases, with clinical vaccine candidates for respiratory syncytial virus (RSV), seasonal influenza and Ebola virus (EBOV) and a preclinical program for a combination respiratory vaccine candidate, as well as other infectious…

ThursdayMay 23, 2019 3:30 pm

Airgain Inc. (AIRG) Starts Presentation at B. Riley Conference

Airgain (NASDAQ: AIRG) is a provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including consumer, enterprise and automotive. Combining design-led thinking with testing and development, Airgain works in partnership with the entire ecosystem, including carriers, chipset suppliers, OEMs and ODMs. Airgain’s antennas are deployed in carrier, fleet, enterprise, residential, private, government and public safety wireless networks and systems, including set-top boxes, access points, routers, modems, gateways, media adapters, portables, digital televisions, sensors, fleet and asset tracking devices. For more information, visit the company's website at www.airgain.com. About NetworkNewsWire…

ThursdayMay 23, 2019 3:30 pm

LiveXLive Media Inc. (LIVX) Starts Presentation at B. Riley Conference

LiveXLive Media (NASDAQ: LIVX) is a global digital media company focused on live entertainment. The company operates LiveXLive, one of the industry's leading live music streaming platforms; Slacker Radio, a streaming music pioneer; and produces original music-related content. LiveXLive is the first 'live social music network,' delivering premium livestreams, digital audio, and on-demand music experiences from the world's top music festivals and concerts, including Rock in Rio, EDC Las Vegas, Hangout Music Festival and many more. Through its owned and operated Internet radio service, Slacker Radio, LiveXLive delivers users access to millions of songs and hundreds of expert-curated stations. For…

ThursdayMay 23, 2019 3:30 pm

Lilis Energy Inc. (LLEX) Starts Presentation at B. Riley Conference

Lilis Energy (NYSE: LLEX) is a Houston-based independent oil and gas exploration and production company that operates in the Permian’s Delaware Basin, considered amongst the leading resource plays in North America. Lilis Energy’s current total net acreage in the Permian Basin is over 20,000 acres. The company’s near-term E&P focus is to grow current reserves and production and pursue strategic acquisitions in its core areas. For more information, visit the company's website at www.lilisenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target…

ThursdayMay 23, 2019 3:30 pm

CalAmp Corp. (CAMP) Starts Presentation at B. Riley Conference

CalAmp (NASDAQ: CAMP) is a technology solutions pioneer transforming the global connected economy. The company helps reinvent business and improve lives around the globe with technology solutions that streamline complex IoT deployments and bring intelligence to the edge. CalAmp’s software applications, scalable cloud services, and intelligent devices collect and assess business-critical data from mobile assets, cargo, companies, cities and people - powering autonomous IoT interaction, facilitating efficient decision making, optimizing resource utilization, and improving road safety. CalAmp is headquartered in Irvine, California, and LoJack is a wholly owned subsidiary of CalAmp. For more information, visit the company's website at www.calamp.com.…

ThursdayMay 23, 2019 3:30 pm

Champion Iron Ltd. (CIA) Starts Presentation at B. Riley Conference

Champion Iron (TSX: CIA) (ASX: CIA) is a producing iron ore exploration and development company with major projects in the southern Labrador Trough, Canada’s largest iron ore-producing region. Champion Iron, through its wholly owned subsidiary Champion Iron Mines Limited, is developing eight iron-rich projects in a 707 km2 area. Each project is strategically located close to the electrical grid, all-season roads and railway lines. This infrastructure connects the projects to a terminal located in water that does not freeze, on the north shore of the Gulf of St. Lawrence. For more information, visit the company's website at www.championiron.com. About NetworkNewsWire…

ThursdayMay 23, 2019 3:30 pm

Heska Corp. (HSKA) Starts Presentation at B. Riley Conference

Heska (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty health care products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, for canine and feline use, Point of Care Laboratory testing instruments and consumables, digital imaging products, software and services, allergy testing and immunotherapy, and in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, for herd animal health, private label vaccine and pharmaceutical production under third-party agreements and channels. For more…

ThursdayMay 23, 2019 2:30 pm

Arbutus Biopharma Corp. (ABUS) Starts Presentation at B. Riley Conference

Arbutus Biopharma (NASDAQ: ABUS) is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Arbutus is developing a portfolio of drug candidates with complementary mechanisms of action that it believes will result in the company’s first novel combination regimen that will transform the HBV treatment landscape and cure hepatitis B virus disease. For more information, visit the company's website at www.arbutusbio.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a…

ThursdayMay 23, 2019 2:30 pm

ArQule Inc. (ARQL) Starts Presentation at B. Riley Conference

ArQule (NASDAQ: ARQL) is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases. ArQule’s mission is to discover, develop and commercialize novel small molecule drugs that will dramatically extend and improve the lives of patients in areas of high unmet need. With four internally discovered drugs in multiple biomarker guided clinical trials and an enriched proprietary kinase library from which to select additional drug candidates, ArQule is delivering on the potential of precision medicine by providing its patients with novel therapies for multiple hard to treat indications. For more information,…